Adding TAR-200 to neoadjuvant cetrelimab improved the pCR rate in patients with muscle-invasive bladder cancer in a phase 2 trial.

The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published online Sept. 3 in JAMA Network Open. Diya Surie ...

Aldosterone increases blood pressure and contributes to chronic kidney disease (CKD) progression. Trial findings suggest baxdrostat may be an effective treatment.

Each additional Geriatric Oncology-PIM linked to 66 percent increase in odds of being mildly, moderate-to-severely frail at diagnosis.

Anrikefon is a kappa opioid receptor agonist with enhanced affinity for the receptor and minimal penetration of the blood-brain barrier.

Greater risk for CVD mortality seen in association with elevated blood pressure and hypertension at age 7 years.

Intervention resulted in a 17 percent absolute improvement in closing BP gaps, increased MA Star performance.

Beyond GLP-1 RA prescriptions, chronic kidney disease (CKD) patients require comprehensive care from doctors, dietitians, & ...

The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of adult patients with BCG-unresponsive, non-muscle invasive bladder cancer with CIS with or without papillary tumors.

Multiparametric MRI was a game changer for prostate cancer diagnosis. Now trial findings suggest a simpler imaging protocol may be as effective.

An investigational factor XI inhibitor shows early promise for treating atrial fibrillation in patients with a degree of kidney impairment.

However, BCC rates similar by College of American Pathologists and Clinical and Laboratory Standards Institute criteria.